Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069082 · ClinicalTrials.gov registry record · Phase 3
Intranasal Civamide for Episodic Cluster Headache
A Phase 3 study, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00069082 is a Phase 3 study that has completed, run by Winston Laboratories. The registered enrollment target is 2 participants.
The verdict
NCT00069082, a Phase 3 study, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Interventions
- DRUG Sodium Chloride
- DRUG Civamide (Zucapsaicin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069082
The ClinicalTrials.gov registry entry for NCT00069082 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winston Laboratories, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Chloride is the first listed.
NCT00069082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00069082 about?
NCT00069082 is a clinical study titled "Intranasal Civamide for Episodic Cluster Headache". This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
What is the current status of trial NCT00069082?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2003-08. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00069082?
The interventions under investigation include: Sodium Chloride (DRUG), Civamide (Zucapsaicin) (DRUG).
Who is sponsoring clinical trial NCT00069082?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.